<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6C0AECD3-7CA8-48B2-AC2C-477F23FCF15A"><gtr:id>6C0AECD3-7CA8-48B2-AC2C-477F23FCF15A</gtr:id><gtr:firstName>Li</gtr:firstName><gtr:otherNames>Fang</gtr:otherNames><gtr:surname>Chan</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600408"><gtr:id>65444E83-29F9-4D17-8CDE-612A22D3B4BE</gtr:id><gtr:title>MRAP2 (Melanocortin Receptor Accessory Protein Two) and its role in melanocortin receptor trafficking and expression</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600408</gtr:grantReference><gtr:abstractText>Familial Glucocorticoid Deficiency (FGD) is a potentially life threatening genetic disease resulting from the adrenal gland being unable to respond to a hormone, ACTH, secreted from the brain. Gene defects in the ACTH receptor have previously been described and account for 25% of cases. The Clark Laboratory has recently found another gene responsible for FGD, called MRAP (Melanocortin 2 Receptor Accessory Protein). Experiments involving MRAP have shed light on the action of ACTH in normal physiology and disease. Searching through the human genome led to the identification of a similar gene called MRAP2. The protein made from this gene has important similarities to MRAP. This MRAP2 protein is therefore likely to interact with ACTH-like receptors. We hypothesise that analyzing the function of MRAP2 will help us understand more about this family of receptors and diseases which arise when they do not function properly.</gtr:abstractText><gtr:technicalSummary>Familial Glucocorticoid Deficiency (FGD) is an autosomal recessive syndrome clinically characterized by unresponsiveness of the adrenal cortex to ACTH. It has been established that mutations in the ACTH receptor (MC2R) itself are responsible for approximately 25% of cases. More recently, the Clark Laboratory has identified a second gene, MRAP (Melanocortin 2 Receptor Accessory Protein), for the cause of FGD. The MRAP gene encodes a single transmembrane domain protein which co-localises with the MC2R in transfected cells. It appears that MRAP is essential in permitting MC2R function acting as a co-factor for the ACTH/MC2R receptor. 

MRAP2 is a highly conserved homologue of MRAP with similar gene structure and is 35% identical at a protein level. We hypothesise that MRAP2 performs an identical co-factor function for one or more other melanocortin receptors. The nature of this interaction, together with the role of MRAP2, is the focus of this fellowship proposal. The study will include: (1) Analysis of the tissue distribution of MRAP2 gene expression (2) Co-immunoprecipitation of MRAP2 and candidate GPCRs and (3) Investigation of the effects of co-expression of MRAP2 with candidate G protein-coupled receptors.

Depending on the interacting partner, the potential scientific and medical opportunities could be immense. The class of melanocortin receptors have been implicated in a wide range of physiological and disease states. The MC1 receptors have relevance to melanoma formation, the MC3 receptors have a complex role in the central regulation of metabolism and the MC4 receptors regulate appetite and food intake. Each of these receptors is the subject of intense pharmaceutical research. If MRAP2 appears to function with any of these receptors, it will be of considerable importance to investigate its genetic contribution to disease. In this instance MRAP2 could potentially become a target for therapeutic manipulation.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>130934</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Ophthalmology UCL</gtr:department><gtr:description>Collaboration on MRAP2 work</gtr:description><gtr:id>5A63FDD0-8638-4CEF-8E7B-DD82C65AF474</gtr:id><gtr:impact>PMID: 19329486 
PMID: 18818285</gtr:impact><gtr:outcomeId>58c0bd1a054e61.81921343-1</gtr:outcomeId><gtr:partnerContribution>Sharing expertise, intellectual input and reagents.</gtr:partnerContribution><gtr:piContribution>Conducting program of work. Sharing data and expertise, intellectual input.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Volunteer for diabetic ski trips</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EE6785F5-5FA9-4596-80CA-581BBBBA25FE</gtr:id><gtr:impact>Annual diabetic ski trip. I escorted diabetic children from Leicester and Newham to the French Alps on the annual 'Diabetic Ski Trip'. I have gained insight into the children's views about their disease.</gtr:impact><gtr:outcomeId>58c6d3ffed4124.61797173</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presenting work to junior doctors and other clinicians</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B0318444-0837-440F-924A-2C91E777A6D0</gtr:id><gtr:impact>Presented research to junior doctors and other clinicians

Provided a forum for discussion regarding the role of molecular research in paediatrics and the opporunty of other paediatric doctors to discuss academic training options.</gtr:impact><gtr:outcomeId>2EE9D029695</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contact with journalist (ENDO meeting)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE6213C4-87F7-423C-B00F-450593E166A9</gtr:id><gtr:impact>My abstract submitted to The Endocrine Society's 88th annual meeting (ENDO), 2006 was selected to be included in the Research Summaries Book (RSB). Each year the Media Advisory Committee and the Public Relations staff of The Endocrine Society identify approximately 100 newsworthy abstracts to be included in the RSB. The book comprises the original abstracts and corresponding lay translations. The RSB acts as a resource for reporters during ENDO and throughout the rest of the year. The Endocrine Society aims to publicise research in the field of endocrinology and the selected abstracts may serve as the basis for a news release and/or press conference.

This was also subsequently published in highlights of the annual meeting in Growth, Genetics and Hormones journal Vol. 22, No. 4, December 2006 57, aimed to facilitate the dissemination of scientific discoveries and advances to a wide audience.</gtr:impact><gtr:outcomeId>8196E0FCE4D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral communication prize that was publicised</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1D4E8160-2013-4270-B023-AC18589E9268</gtr:id><gtr:impact>In 2008, I presented my research at the Society for Endocrinology, and was awarded the: 'Young Endocrinologist oral communication prize in basic science' (2008).

The award and research was publicised on the society website and in the form of a national news letter.</gtr:impact><gtr:outcomeId>910D235F5F9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>550</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>C8A968DA-68CB-4AA5-B98C-26A493C72FB2</gtr:id><gtr:outcomeId>SZoJu9ooPTa0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International travel grant</gtr:description><gtr:end>2008-06-02</gtr:end><gtr:fundingOrg>Society for Endocrinology</gtr:fundingOrg><gtr:id>2B5E2382-004B-436B-A74D-5BAB01ABAD8F</gtr:id><gtr:outcomeId>mmWmMVj6Ri50</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Novo Nordisk</gtr:fundingOrg><gtr:id>B5E7AED6-7842-420E-AD06-DEE1E942A809</gtr:id><gtr:outcomeId>BF5ipHNUbjH0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>850000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Tenure Track MRC/Academy of Medical Sciences Clinician Scientist Fellowship</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0802796</gtr:fundingRef><gtr:id>7324986E-4702-4692-8103-53C4463F5B00</gtr:id><gtr:outcomeId>F67F7EBEF930</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant</gtr:description><gtr:end>2007-03-02</gtr:end><gtr:fundingOrg>Society for Endocrinology</gtr:fundingOrg><gtr:id>93B0A3E0-5AF7-4F49-BF59-774034CE1F07</gtr:id><gtr:outcomeId>nXQSGQAZjLA0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>130</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research Foundation for the State University of New York</gtr:department><gtr:description>Travel award/The research foundation of the state university of New York</gtr:description><gtr:end>2008-06-02</gtr:end><gtr:fundingOrg>State University of New York</gtr:fundingOrg><gtr:id>A27C55F1-D293-4329-95EC-63D1085223DE</gtr:id><gtr:outcomeId>kQuy9hFdExS0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Plasmids made as part of funding obtained from MRC.</gtr:description><gtr:id>73BC505D-F144-4054-B3D4-A9F80D608FE3</gtr:id><gtr:impact>Shared reagents lead to the following publication: 
Mol Endocrinol. 2014 Sep;28(9):1547-57. doi: 10.1210/me.2014-1105. Epub 2014 Jul 22.
Melanocortin 3 receptor has a 5' exon that directs translation of apically localized protein from the second in-frame ATG.
Park J1, Sharma N, Cutting GR.</gtr:impact><gtr:outcomeId>atJdAdySzvs</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Plasmids generated as part of funding from MRC</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/25051171</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Generation of polyclonal antibody</gtr:description><gtr:id>9BE8A032-C039-4B9D-9E18-8D648F41AF9D</gtr:id><gtr:impact>Reagent used in collaborative work.</gtr:impact><gtr:outcomeId>CzyEkHYTEoP</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Generation of antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0455D16E-2BE0-4B56-81CE-E12BF1B7946B</gtr:id><gtr:title>MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>CAF53994129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93A3887A-050D-4471-940E-D9CE5DF7B4CF</gtr:id><gtr:title>The genetics of ACTH resistance syndromes.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efffd827f4cf03299dd1a9576ea0f846"><gtr:id>efffd827f4cf03299dd1a9576ea0f846</gtr:id><gtr:otherNames>Metherell LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>0BE239AA412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E01B9E8-7912-4141-8B62-EC289160C67D</gtr:id><gtr:title>Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>F519FB0B037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC265A37-CAE2-4EC4-BF8B-978312DB191B</gtr:id><gtr:title>Accessory proteins are vital for the functional expression of certain G protein-coupled receptors.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13f565af01e8b797b5e7db33536e446"><gtr:id>b13f565af01e8b797b5e7db33536e446</gtr:id><gtr:otherNames>Cooray SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>07824758277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8EA14BD-0807-42FD-8150-73AB064C45CF</gtr:id><gtr:title>Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd8da0dddbb04c15088623de9bc1d323"><gtr:id>bd8da0dddbb04c15088623de9bc1d323</gtr:id><gtr:otherNames>Dias RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>8A92E9E65A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6C143F0-7E86-43AC-BD2E-2B191AF2CD1A</gtr:id><gtr:title>The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2ca63c2242b9dacfc3a53571390c4b"><gtr:id>7d2ca63c2242b9dacfc3a53571390c4b</gtr:id><gtr:otherNames>Chung TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>851C3102886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB9A6CCA-F2CE-49E9-91E3-1ACDB8EB175F</gtr:id><gtr:title>Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action.</gtr:title><gtr:parentPublicationTitle>Hormone research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0301-0163</gtr:issn><gtr:outcomeId>975228C67AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8BC7F3E-B189-4640-B2D3-EB3D9044D3D7</gtr:id><gtr:title>A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd61cdba975d065335ad2dbd813ed060"><gtr:id>fd61cdba975d065335ad2dbd813ed060</gtr:id><gtr:otherNames>O'Riordan SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>AC79C2DB6AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D810077B-0F3E-4A60-9FD7-CC91E8D5E2A2</gtr:id><gtr:title>The genetics of familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1cc2aa8d2d6d1ed6ad73bf575ba1f1f"><gtr:id>f1cc2aa8d2d6d1ed6ad73bf575ba1f1f</gtr:id><gtr:otherNames>Clark AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>1313CA10E66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFBC3A51-980F-4A60-9B22-FA0EC293A150</gtr:id><gtr:title>Distinct melanocortin 2 receptor accessory protein domains are required for melanocortin 2 receptor interaction and promotion of receptor trafficking.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33381ab1beaa715f676ae658ca8aecbd"><gtr:id>33381ab1beaa715f676ae658ca8aecbd</gtr:id><gtr:otherNames>Webb TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>6D8AC9C8C45</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5B99BFE-A3A2-40A4-8E2A-6C3826F54DB6</gtr:id><gtr:title>Adrenocorticotropin resistance syndromes.</gtr:title><gtr:parentPublicationTitle>Endocrine development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13f565af01e8b797b5e7db33536e446"><gtr:id>b13f565af01e8b797b5e7db33536e446</gtr:id><gtr:otherNames>Cooray SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1421-7082</gtr:issn><gtr:outcomeId>FB5C8AEE0A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA5F6A45-7E73-47CE-B584-ADBDE5B5EDA2</gtr:id><gtr:title>Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2ca63c2242b9dacfc3a53571390c4b"><gtr:id>7d2ca63c2242b9dacfc3a53571390c4b</gtr:id><gtr:otherNames>Chung TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>0F9498C07A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2B19AB5-CB99-43BD-A702-CBF750CD58A1</gtr:id><gtr:title>Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long-term mineralocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>1383DC478DB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600408</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>